| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8457671 | Nuclear Medicine and Biology | 2018 | 8 Pages |
Abstract
The radiochemical stability in combination with a successful in vivo tumor uptake shows the potential suitability for future RIT applications with the 6A10 Fab.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![Evaluation of 177Lu[Lu]-CHX-Aâ³-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII](/preview/png/8457671.png "First Page Preview: Evaluation of 177Lu[Lu]-CHX-Aâ³-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII")
Authors
L. Fiedler, M. Kellner, A. Gosewisch, R. Oos, G. Böning, S. Lindner, N. Albert, P. Bartenstein, H.-J. Reulen, R. Zeidler, F.J. Gildehaus,